|
CG50201 |
C49H66N10O10S2, MW: 1019.2(D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-Ol) |
1 g |
1.840 |
|
CG50201 |
MF: C49H66N10O10S2, MW:
1019.2(D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-Ol(Disulfide bridge
Cys2-Cys7)) |
100 mg |
1.164 |
|
CG50301 |
MF: C129H215N33O55, MW:
3108.3(Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn) |
1 g |
4.115 |
|
CG50301 |
MF: C129H215N33O55, MW:
3108.3(Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn) |
0.5 mg |
423 |
|
CG50301 |
MF: C129H215N33O55, MW:
3108.3(Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn) |
1 mg |
1.138 |
|
CG50301 |
MF: C129H215N33O55, MW:
3108.3(Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn) |
2.5 mg |
3.998 |
|
CG50401 |
MF: C137H207N41O39S3, MW:
3148.6(Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide
bridge Cys17-Cys28)) |
2.5 mg |
410 |
|
CG50401 |
MF: C137H207N41O39S3, MW:
3148.6(Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide
bridge Cys17-Cys28)) |
1 mg |
280 |
|
CG50401 |
MF: C137H207N41O39S3, MW:
3148.6(Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide
bridge Cys17-Cys28)) |
0.5 mg |
202 |
|
CG50501 |
MF: C43H66N12O12S2, MW:
1007.2(Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2Disulfide bridge
Cys1-Cys6) |
5 mg |
176 |
|
CG50501 |
MF: C43H66N12O12S2, MW:
1007.2(Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2Disulfide bridge
Cys1-Cys6) |
1000 mg |
2.880 |
|
CG50601 |
MF: C37H52N8O10, MW: 768.87(Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2) |
5 mg |
202 |
|
CG50601 |
MF: C37H52N8O10, MW: 768.87(Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2) |
10 mg |
280 |
|
CG50601 |
MF: C37H52N8O10, MW: 768.87(Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2) |
25 mg |
410 |
|
CG50701 |
MF: C47H58N12O6, MW: 887(His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2) |
5 mg |
358 |
|
CG50701 |
MF: C47H58N12O6, MW: 887(His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2) |
50 mg |
1.398 |
|
CG50904 |
MF: C57H70N12O9S2, MW: 1131.4(D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2) |
1 mg |
189 |
|
CG50904 |
MF: C57H70N12O9S2, MW: 1131.4(D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2) |
2.5 mg |
267 |
|
CG50904 |
MF: C57H70N12O9S2, MW: 1131.4(D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2) |
0.5 mg |
163 |
|
CG51014 |
MF: C92H150N28O29, MW:
2112.4(Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH) |
1 mg |
202 |
|
CG51014 |
MF: C92H150N28O29, MW:
2112.4(Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH) |
2.5 mg |
293 |
|
CG51014 |
MF: C92H150N28O29, MW:
2112.4(Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH) |
0.5 mg |
176 |
|
CG51018 |
MF: C151H226N40O46, MW:
3337.73(H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH) |
0.5 mg |
228 |
|
CG51018 |
MF: C151H226N40O46, MW:
3337.73(H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH) |
1 mg |
358 |
|
CG51018 |
MF: C151H226N40O46, MW:
3337.73(H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH) |
2.5 mg |
488 |
|
CG51020 |
MF: C22H26N4O6, MW: 442.48(Tyr-Gly-Gly-Phe-OH) |
25 mg |
176 |
|
CG51023 |
MF: C74H120N26O25, MW:
1773.9(Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-OH) |
2 mg |
358 |
|
CG51023 |
MF: C74H120N26O25, MW:
1773.9(Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-OH) |
5 mg |
488 |
|
CG51023 |
MF: C74H120N26O25, MW:
1773.9(Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-OH) |
1 mg |
228 |
|
CG51029 |
MF: C53H79N13O10, MW: 1058.3(Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val) |
5 mg |
176 |
|
CG51068 |
MW: (Gly-His-Lys) |
|
Inquire |
|
CG51081 |
MF: C59H84N16O12, MW:
1209.43(pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt) |
1 g |
1.840 |
|
CG51081 |
MF: C59H84N16O12, MW:
1209.4(pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt) |
5 mg |
176 |
|
CG51102 |
MF: C43H68N10O15, MW: 965.08(Tyr-Leu-Ser-Gly-Ala-Asp-Leu-Asn-Leu-OH) |
5 mg |
176 |
|
CG51106 |
MF: C45H81N13O14S1, MW:
1060.3(H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH) |
5 mg |
176 |
|
CG51175 |
MF: C43H69N11O14, MW: 964.09(Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu-OH) |
5 mg |
176 |
|
CG51177 |
MF: C49H75N9O20, MW: 1110.19(Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr-OH) |
5 mg |
176 |
|
CG51370 |
MF: C49H75N9O11, MW: 966.2(Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu-OH) |
5 mg |
176 |
|
CG51381 |
MF: C36H42N18O6, MW: 822.85(His-His-His-His-His-His-OH) |
5 mg |
254 |
|
CG51419 |
MF: C204H301N51O64, MW:
4492.01(Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2) |
1 g |
6.618 |
|
CG51419 |
MF: C204H301N51O64, MW:
4462(CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2) |
1 mg |
228 |
|
CG51419 |
MF: C204H301N51O64, MW:
4462(CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2) |
2 mg |
358 |
|
CG51419 |
MF: C204H301N51O64, MW:
4462(CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2) |
5 mg |
488 |
|
CG51455 |
MF: C80H129N19O23 , MW:
11725.03(Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu) |
1 mg |
137 |
|
CG51455 |
MF: C80H129N19O23 , MW:
11725.03(Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu) |
2 mg |
163 |
|
CG51455 |
MF: C80H129N19O23 , MW:
11725.03(Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu) |
5 mg |
228 |
|
CG51458 |
MF: C45H72N14O12, MW: 1001.16(His-Leu-Ser-Thr-Ala-Phe-Ala-Arg-Val-OH) |
5 mg |
176 |
|
CG51473 |
C35H49N11O9S2, MW: 832.4(Map-Har-Gly-Asp-Trp-Pro-Cys-NH2) |
1 g |
3.433 |
|
CG51473 |
MF: C35H49N11O9S2, MW: 832.4(Map-Har-Gly-Asp-Trp-Pro-Cys-NH2(Disulfide
bridge, Map1-Cys6)) |
25 mg |
488 |
|
CG51473 |
MF: C35H49N11O9S2, MW: 832.4(Map-Har-Gly-Asp-Trp-Pro-Cys-NH2(Disulfide
bridge, Map1-Cys6)) |
5 mg |
228 |
|
CG51473 |
MF: C35H49N11O9S2, MW: 832.4(Map-Har-Gly-Asp-Trp-Pro-Cys-NH2(Disulfide
bridge, Map1-Cys6)) |
10 mg |
358 |
|
CG51478 |
MF: C37H67N9O11, MW: 814(Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val) |
1 mg |
137 |
|
CG51478 |
MF: C37H67N9O11, MW: 814(Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val) |
2 mg |
163 |
|
CG51478 |
MF: C37H67N9O11, MW: 814(Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val) |
5 mg |
228 |
|
CG51480 |
MF: C50H71N13O12, MW: 1046.19(Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) |
25 mg |
176 |
|
CG51489 |
MF: C26H33N5O7, MW: 527.6(Z-Ala-Ala-Leu-pNA) |
100 mg |
176 |
|
CG51489 |
MF: C26H33N5O7, MW: 527.6(Z-Ala-Ala-Leu-pNA) |
250 mg |
228 |
|
CG51514 |
MF: C147H245N45O42, MW:
3314.8(Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-
Arg-OH) |
1 mg |
280 |
|
CG51514 |
MF: C147H245N45O42, MW:
3314.8(Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-
Arg-OH) |
5 mg |
748 |
|
CG51515 |
MF: C149H249N47O42, MW:
3370.9(Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH) |
1 mg |
280 |
|
CG51515 |
MF: C149H249N47O42, MW:
3370.9(Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg-OH) |
5 mg |
748 |
|
CG51516 |
MF: C194H295N53O58S1, MW:
4329.9(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH) |
0.5 mg |
267 |
|
CG51516 |
MF: C194H295N53O58S1, MW:
4329.9(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH) |
1 mg |
384 |
|
CG51516 |
MF: C194H295N53O58S1, MW:
4329.9(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH) |
2.5 mg |
618 |
|
CG51527 |
MF: C6H12N2O3, MW: 160.17(D-Ala-D-Ala-OH) |
250 mg |
144 |
|
CG51529 |
MF: C13H13N3O2, MW: 261.28(Trp-Gly) |
250 mg |
566 |
|
CG51534 |
MF: C44H66N12O12, MW: 955.09(Arg-Gly-Tyr-Val-Tyr-Gln-Gly-Leu-OH) |
5 mg |
176 |
|
CG51546 |
MF: C26H34N6O13, MW: 638.6(Ac-Asp-Glu-Val-Asp-pNA) |
5 mg |
176 |
|
CG51550 |
MF: C147H238N44O42S1, MW:
3225.7(His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2) |
2.5 mg |
293 |
|
CG51550 |
MF: C147H238N44O42S1, MW:
3225.7(His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2) |
1 mg |
202 |
|
CG51588 |
MF: C119H204N34O32S2, MW:
2687.28(Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH) |
0.5 mg |
202 |
|
CG51588 |
MF: C119H204N34O32S2, MW:
2687.28(Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH) |
1 mg |
280 |
|
CG51588 |
MF: C119H204N34O32S2, MW:
2687.28(Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH) |
2.5 mg |
410 |
|
CG51607 |
MF: C73H127N29O18, MW:
1699.01(H-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-OH) |
2 mg |
293 |
|
CG51607 |
MF: C73H127N29O18, MW:
1699.01(H-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-OH) |
5 mg |
462 |
|
CG51607 |
MF: C73H127N29O18, MW:
1699.01(H-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-OH) |
1 mg |
215 |
|
CG51613 |
MF: C138H230N46O34S4, MW:
3205.9(Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Gly-Ser-Tyr-Cys-Asn-Arg-Arg-Thr-Gly-Lys-Cys-Gln-Arg-Met) |
2 mg |
280 |
|
CG51613 |
MF: C138H230N46O34S4, MW:
3205.9(Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Gly-Ser-Tyr-Cys-Asn-Arg-Arg-Thr-Gly-Lys-Cys-Gln-Arg-Met) |
5 mg |
410 |
|
CG51613 |
MF: C138H230N46O34S4, MW:
3205.9(Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Gly-Ser-Tyr-Cys-Asn-Arg-Arg-Thr-Gly-Lys-Cys-Gln-Arg-Met) |
1 mg |
202 |
|
CG51614 |
MF: C28H43N9O9, MW: 649.7(Ac-Ile-Glu-Ala-Arg-pNA) |
25 mg |
651 |
|
CG51628 |
MF: C28H34N4O7S1, MW: 571.63(Dansyl-Tyr-Val-Gly) |
25 mg |
215 |
|
CG51628 |
MF: C28H34N4O7S1, MW: 571.63(Dansyl-Tyr-Val-Gly) |
50 mg |
293 |
|
CG51628 |
MF: C28H34N4O7S1, MW: 571.63(Dansyl-Tyr-Val-Gly) |
125 mg |
462 |
|
CG51668 |
MF: C38H64N8O15, MW: 872.97(Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr-OH) |
5 mg |
215 |
|
CG51684 |
MF: C19H26N8O6, MW: 462.5(Pyr-Gly-Arg-pNA) |
1 mg |
137 |
|
CG51684 |
MF: C19H26N8O6, MW: 462.5(Pyr-Gly-Arg-pNA) |
10 mg |
228 |
|
CG51715 |
MF: C80H138N26O24S2, MW:
1912.28(H-Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-OH) |
1 mg |
163 |
|
CG51715 |
MF: C80H138N26O24S2, MW:
1912.28(H-Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-OH) |
2 mg |
189 |
|
CG51715 |
MF: C80H138N26O24S2, MW:
1912.28(H-Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-OH) |
5 mg |
267 |
|
CG51716 |
MF: C118H177N35O29S, MW:
2582(Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH) |
1 mg |
202 |
|
CG51716 |
MF: C118H177N35O29S, MW:
2582(Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH) |
2 mg |
280 |
|
CG51716 |
MF: C118H177N35O29S, MW:
2582(Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH) |
5 mg |
410 |
|
CG51725 |
MF: C44H59N13O10S1, MW: 962.1(H-Met-Glu-His-Phe-Arg-Trp-Gly-OH) |
5 mg |
176 |
|
CG51769 |
MF: C64H83N18O13, MW:
1311.5(Glp-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2) |
25 mg |
176 |
|
CG51771 |
MF: C42H60N14O16S4, MW:
1145.29(H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-OH（Cys2-Cys10 ,
Cys4-Cys8）) |
1 mg |
202 |
|
CG51771 |
MF: C42H60N14O16S4, MW:
1145.29(H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-OH（Cys2-Cys10 ,
Cys4-Cys8）) |
2 mg |
280 |
|
CG51771 |
MF: C42H60N14O16S4, MW:
1145.29(H-Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly-OH（Cys2-Cys10 ,
Cys4-Cys8）) |
5 mg |
410 |
|
CG51772 |
MF: C78H111N21O19, MW: 1646.9() |
25 mg |
293 |
|
CG51772 |
MF: C78H111N21O19, MW:
1646.9(Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) |
5 mg |
176 |
|
CG51772 |
MF: C78H111N21O19, MW:
1646.9(Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) |
10 mg |
202 |
|
CG51772 |
MF: C78H111N21O19, MW:
1646.9(Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) |
25 mg |
293 |
|
CG51786 |
MF: C46H78N12O12, MW: 991.21(H-Ile-Leu-Lys-Glu-Pro-Val-His-Gly-Val-OH) |
5 mg |
176 |
|
CG51791 |
MF: C44H72N10O15, MW: 981.1(Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-OH) |
1 mg |
176 |
|
CG51791 |
MF: C44H72N10O15, MW: 981.1(Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-OH) |
2 mg |
202 |
|
CG51791 |
MF: C44H72N10O15, MW: 981.1(Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-OH) |
5 mg |
293 |
|
CG51895 |
MF: C129H211N35O48, MW:
3020.33(H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH) |
0.5 mg |
228 |
|
CG51895 |
MF: C129H211N35O48, MW:
3020.33(H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH) |
1 mg |
358 |
|
CG51895 |
MF: C129H211N35O48, MW:
3020.33(H-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-OH) |
2.5 mg |
488 |
|
CG51916 |
MF: C52H88N22O17, MW:
1293.42(Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly-OH) |
1 mg |
137 |
|
CG51916 |
MF: C52H88N22O17, MW:
1293.42(Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly-OH) |
2 mg |
163 |
|
CG51916 |
MF: C52H88N22O17, MW:
1293.42(Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly-OH) |
5 mg |
228 |
|
CG51920 |
MF: C180H287N57O48, MW:
4017.65(H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH) |
0.5 mg |
215 |
|
CG51920 |
MF: C180H287N57O48, MW:
4017.65(H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH) |
1 mg |
293 |
|
CG51920 |
MF: C180H287N57O48, MW:
4017.65(H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH) |
2.5 mg |
462 |
|
CG51961 |
MF: C20H33N5O9, MW: 487.51(Ac-Ser-Asp-Lys-Pro-OH) |
10 mg |
189 |
|
CG51961 |
MF: C20H33N5O9, MW: 487.51(Ac-Ser-Asp-Lys-Pro-OH) |
25 mg |
267 |
|
CG51961 |
MF: C20H33N5O9, MW: 487.51(Ac-Ser-Asp-Lys-Pro-OH) |
5 mg |
163 |
|
CG51978 |
MF: C29H36N6O10, MW: 628.6(Ac-Tyr-Val-Ala-Asp-pNA) |
25 mg |
586 |
|
CG51999 |
MF: C29H38N8O11, MW: 674.7(Ac-Leu-Glu-His-Asp-pNA) |
5 mg |
176 |
|
CG52000 |
MF: C28H40N6O11, MW: 636.6(Ac-Val-Glu-Ile-Asp-pNA) |
25 mg |
651 |
|
CG52001 |
MF: C27H38N6O12, MW: 638.6(Ac-Ile-Glu-Thr-Asp-pNA) |
25 mg |
651 |
|
CG52003 |
MF: C23H32N6O7, MW: 504.5(Ac-Gly-Pro-Lys(Ac)-pNA) |
25 mg |
651 |
|
CG52004 |
MF: C21H30N6O6, MW: 462.5(Ac-Gly-Pro-Lys-pNA) |
25 mg |
651 |
|
CG52142 |
MF: C66H103N17O17, MW:
1406.64(H-Thr-Pro-Pro-Ala-Tyr-Arg-Pro-Pro-Asn-Ala-Pro-Ile-Leu-OH) |
2.5 mg |
176 |
|
CG52143 |
MF: C184H282N50O60S1, MW:
4186.03(H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2) |
0.5 mg |
293 |
|
CG52143 |
MF: C184H282N50O60S1, MW:
4186.03(H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2) |
1 mg |
436 |
|
CG52143 |
MF: C184H282N50O60S1, MW:
4186.03(H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2) |
2.5 mg |
696 |
|
CG52189 |
MF: C50H69N15O9, MW: 1024.2(Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2) |
1 g |
2.750 |
|
CG52189 |
MF: C50H69N15O9, MW: 1024.2(Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2(Lactam
bridge Asp2-Lys7)) |
10 mg |
254 |
|
CG52189 |
MF: C50H69N15O9, MW: 1024.2(Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2(Lactam
bridge Asp2-Lys7)) |
25 mg |
371 |
|
CG52189 |
MF: C50H69N15O9, MW: 1024.2(Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2(Lactam
bridge Asp2-Lys7)) |
5 mg |
189 |
|
CG52217 |
MF: C43H58N11O11, MW: 903.9(pGlu-Leu-Asn-Phe-Ser-Ala-Gly-Trp-NH2) |
5 mg |
176 |
|
CG52218 |
MF: C44H60N11O12, MW: 934(pGlu-Leu-Asn-Phe-Ser-Thr-Gly-Trp-NH2) |
5 mg |
176 |
|
CG52219 |
MF: C165H261N51O55S2, MW:
.3903.4(H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2) |
0.5 mg |
215 |
|
CG52219 |
MF: C165H261N51O55S2, MW:
.3903.4(H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2) |
2.5 mg |
462 |
|
CG52219 |
MF: C165H261N51O55S2, MW:
.3903.4(H-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2) |
1 mg |
462 |
|
CG52220 |
MF: C62H89N17O14, , MW:
1296.5(H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH) |
25 mg |
145 |
|
CG52221 |
MF: C76H104N18O19S2, MW:
1637.9(Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH
(Disulfide bridge Cys3-Cys14)) |
25 mg |
267 |
|
CG52221 |
MF: C76H104N18O19S2, MW:
1637.9(Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH
(Disulfide bridge Cys3-Cys14)) |
5 mg |
163 |
|
CG52221 |
MF: C76H104N18O19S2, MW:
1637.9(Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH
(Disulfide bridge Cys3-Cys14)) |
10 mg |
189 |
|
CG52222 |
MF: C46H66N12O9,, MW: 931.1(H-Arg-Val-Tyr-Ile-His-Pro-Phe-OH) |
25 mg |
176 |
|
CG52223 |
MF: C127H203N45O39S3, MW:
3080.46(Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide
bridge Cys7-Cys23)) |
2.5 mg |
488 |
|
CG52223 |
MF: C127H203N45O39S3, MW:
3080.46(Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide
bridge Cys7-Cys23)) |
0.5 mg |
228 |
|
CG52223 |
MF: C127H203N45O39S3, MW:
3080.46(Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide
bridge Cys7-Cys23)) |
1 mg |
358 |
|
CG52224 |
MF: C63H118N24O13S2, MW:
1483.9(H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH（Cys3-Cys11）) |
1 mg |
163 |
|
CG52224 |
MF: C63H118N24O13S2, MW:
1483.9(H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH（Cys3-Cys11）) |
2 mg |
189 |
|
CG52224 |
MF: C63H118N24O13S2, MW:
1483.9(H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH（Cys3-Cys11）) |
5 mg |
267 |
|
CG52225 |
MF: C62H101N17O19, MW:
1388.58(Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-OH) |
1 mg |
189 |
|
CG52225 |
MF: C62H101N17O19, MW:
1388.58(Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-OH) |
2 mg |
254 |
|
CG52225 |
MF: C62H101N17O19, MW:
1388.58(Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-OH) |
5 mg |
371 |
|
CG52226 |
MF: C71H111N24O18S, MW:
1619.86(H-pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-) |
5 mg |
163 |
|
CG52227 |
MF: C50H73N15O11, MW: 1060.22(Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) |
50 mg |
176 |
|
CG52228 |
MF: C45H72N12O15S, MW:
1053.2(Gly-Met-Asp-Ser-Leu-Ala-Phe-Ser-Gly-Gly-Leu-NH2) |
5 mg |
176 |
|
CG52229 |
MF: C151H226N40O45S3, MW:
3417.87(Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide
bridge Cys1-Cys7)) |
2.5 mg |
293 |
|
CG52229 |
MF: C151H226N40O45S3, MW:
3417.87(Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide
bridge Cys1-Cys7)) |
1 mg |
202 |
|
CG52229 |
MF: C151H226N40O45S3, MW:
3417.87(Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide
bridge Cys1-Cys7)) |
0.5 mg |
176 |
|
CG52230 |
MF: C145H240N44O48S2, MW:
3417.88(Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide
bridge Cys1-Cys7)) |
2.5 mg |
267 |
|
CG52230 |
MF: C145H240N44O48S2, MW:
3417.88(Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide
bridge Cys1-Cys7)) |
1 mg |
189 |
|
CG52230 |
MF: C145H240N44O48S2, MW:
3417.88(Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide
bridge Cys1-Cys7)) |
0.5 mg |
163 |
|
CG52231 |
MF: C163H267N51O49S2, MW:
3789.33(Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide
bridge Cys2-Cys7)) |
0.5 mg |
228 |
|
CG52231 |
MF: C163H267N51O49S2, MW:
3789.33(Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide
bridge Cys2-Cys7)) |
1 mg |
358 |
|
CG52231 |
MF: C163H267N51O49S2, MW:
3789.33(Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide
bridge Cys2-Cys7)) |
2.5 mg |
488 |
|
CG52232 |
MF: C162H267N51O48S3, MW:
3793.38(Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide
bridge Cys2-Cys7)) |
2.5 mg |
488 |
|
CG52232 |
MF: C162H267N51O48S3, MW:
3793.38(Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide
bridge Cys2-Cys7)) |
1 mg |
358 |
|
CG52232 |
MF: C162H267N51O48S3, MW:
3793.38(Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide
bridge Cys2-Cys7)) |
0.5 mg |
228 |
|
CG52233 |
MF: C93H157N27O28S3, MW:
2197.64(H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH（Cys6-Cys22）) |
1 mg |
280 |
|
CG52233 |
MF: C93H157N27O28S3, MW:
2197.64(H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH（Cys6-Cys22）) |
2.5 mg |
410 |
|
CG52233 |
MF: C93H157N27O28S3, MW:
2197.64(H-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-OH（Cys6-Cys22）) |
0.5 mg |
202 |
|
CG52234 |
MF: C208H344N60O63S2, MW:
4575.5(H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-LeuvAla-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ilev-NH2) |
2.5 mg |
488 |
|
CG52234 |
MF: C208H344N60O63S2, MW:
4575.5(H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-LeuvAla-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ilev-NH2) |
0.5 mg |
228 |
|
CG52234 |
MF: C208H344N60O63S2, MW:
4575.5(H-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-LeuvAla-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ilev-NH2) |
1 mg |
358 |
|
CG52235 |
MF: C81H113N19O19S2, MW:
1721.05(H-Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH（Cys2-Cys13）) |
2.5 mg |
566 |
|
CG52235 |
MF: C81H113N19O19S2, MW:
1721.05(H-Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH（Cys2-Cys13）) |
1 mg |
358 |
|
CG52235 |
MF: C81H113N19O19S2, MW:
1721.05(H-Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH（Cys2-Cys13）) |
0.5 mg |
254 |
|
CG52236 |
MF: C48H70N10O7, MW: 899.14(H-Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2) |
1 mg |
137 |
|
CG52236 |
MF: C48H70N10O7, MW: 899.14(H-Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2) |
2 mg |
163 |
|
CG52236 |
MF: C48H70N10O7, MW: 899.14(H-Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2) |
5 mg |
228 |
|
CG52237 |
MF: C74H119N25O14, MW:
1582.91(H-Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2) |
2 mg |
202 |
|
CG52237 |
MF: C74H119N25O14, MW:
1582.91(H-Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2) |
5 mg |
293 |
|
CG52237 |
MF: C74H119N25O14, MW:
1582.91(H-Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2) |
1 mg |
176 |
|
CG52238 |
MF: C40H50N8O10, MW: 802.88(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) |
25 mg |
410 |
|
CG52238 |
MF: C40H50N8O10, MW: 802.88(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) |
5 mg |
202 |
|
CG52238 |
MF: C40H50N8O10, MW: 802.88(Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) |
10 mg |
280 |
|
CG52239 |
MF: C152H257N43O44S2, MW:
3455.08(Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Leu-Gly-Ala-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln) |
0.5 mg |
189 |
|
CG52239 |
MF: C152H257N43O44S2, MW:
3455.08(Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Leu-Gly-Ala-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln) |
1 mg |
254 |
|
CG52239 |
MF: C152H257N43O44S2, MW:
3455.08(Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Leu-Gly-Ala-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln) |
2.5 mg |
371 |
|
CG52240 |
MF: C46H64N14O12S2, MW:
1069.1(Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide bridge,
Map1-Cys6)) |
1 mg |
176 |
|
CG52240 |
MF: C46H64N14O12S2, MW:
1069.1(Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide bridge,
Map1-Cys6)) |
2 mg |
202 |
|
CG52240 |
MF: C46H64N14O12S2, MW:
1069.1(Map-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(Disulfide bridge,
Map1-Cys6)) |
5 mg |
293 |
|
CG52241 |
MF: C108H167N27O29, MW:
2307.67(Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys) |
5 mg |
488 |
|
CG52241 |
MF: C108H167N27O29, MW:
2307.67(Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys) |
1 mg |
228 |
|
CG52241 |
MF: C108H167N27O29, MW:
2307.67(Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys) |
2 mg |
358 |
|
CG52242 |
MF: C27H36N6O6S1, MW: 572.69(H-Ala-Pro-Gly-Pro-Arg-OH) |
5 mg |
176 |
|
CG52243 |
MF: C25H42N8O8, MW: 582.66(H-Val-Pro-Asp-Pro-Arg-OH) |
5 mg |
176 |
|
CG52244 |
MF: C31H52N8O6S, MW: 664.86(Met-Arg-Leu-Phe-Val-OH) |
5 mg |
176 |
|
CG52245 |
MF: C50H80N18O16, MW:
1189.29(His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH) |
1 mg |
137 |
|
CG52245 |
MF: C50H80N18O16, MW:
1189.29(His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH) |
2 mg |
163 |
|
CG52245 |
MF: C50H80N18O16, MW:
1189.29(His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH) |
5 mg |
228 |
|
CG52246 |
MF: C25H39N7O8, MW: 565.63(Glu-His-Ile-Pro-Ala-OH) |
25 mg |
215 |
|
CG52247 |
MF: C18H31N7O5, MW: 425.49(Gly-Pro-Arg-Pro-OH) |
5 mg |
176 |
|
CG52248 |
MF: C29H42N8O4S, MW: 598.76(Phe-Met-Arg-Phe-NH2) |
1 mg |
137 |
|
CG52249 |
MF: C44H62N11O10, MW: 904.03(pGlu-Asp-Pro-Phe-Leu-Arg-Phe-NH2) |
1 mg |
176 |
|
CG52250 |
MF: C139H210N42O43, MW:
3157.44(Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser-OH) |
1 mg |
358 |
|
CG52251 |
MF: C141H211N43O41, MW:
3164.48(Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-NH2) |
1 mg |
358 |
|
CG52252 |
MF: C146H213N43O40, MW:
3210.55(Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala-NH2) |
1 mg |
358 |
|
CG52253 |
MF: C97H125N20O31S, MW:
2098.22(pGlu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) |
5 mg |
410 |
|
CG52253 |
MF: C97H125N20O31S, MW:
2098.22(pGlu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) |
1 mg |
202 |
|
CG52253 |
MF: C97H125N20O31S, MW:
2098.22(pGlu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) |
2 mg |
280 |
|
CG52254 |
MF: C130H204N38O31S2, MW:
2859.4(Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2) |
1 mg |
293 |
|
CG52255 |
MF: C126H198N38O31S2, MW:
2805.4(Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2) |
1 mg |
293 |
|
CG52256 |
MF: C153H225N43O49S, MW:
3482.78(His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr) |
1 mg |
277 |
|
CG52257 |
MF: C215H358N72O66S1, MW:
5039.7(H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2) |
2.5 mg |
553 |
|
CG52257 |
MF: C215H358N72O66S1, MW:
5039.7(H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2) |
0.5 mg |
248 |
|
CG52257 |
MF: C215H358N72O66S1, MW:
5039.7(H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2) |
1 mg |
358 |
|
CG52258 |
MF: C176H285N47O49, MW:
3843.47(His-Ser-Asp-Ala-Ile-Phe-Thr-Gln-Gln-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Ala-Ser-Ile-Leu-Gly-Ser-Arg-Thr-Ser-Pro-Pro-Pro-NH2) |
1 mg |
379 |
|
CG52259 |
MF: C49H64N12O11, MW: 997.12(Tyr-Pro-Trp-Thr-Gln-Arg-Phe-OH) |
1 mg |
59 |
|
CG52259 |
MF: C49H64N12O11, MW: 997.12(Tyr-Pro-Trp-Thr-Gln-Arg-Phe-OH) |
2 mg |
163 |
|
CG52259 |
MF: C49H64N12O11, MW: 997.12(Tyr-Pro-Trp-Thr-Gln-Arg-Phe-OH) |
5 mg |
228 |
|
CG52260 |
MF: C42H77N9O11, MW: 884.12(H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH) |
1 mg |
137 |
|
CG52260 |
MF: C42H77N9O11, MW: 884.12(H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH) |
2 mg |
163 |
|
CG52260 |
MF: C42H77N9O11, MW: 884.12(H-Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu-OH) |
5 mg |
228 |
|
CG52261 |
MF: C46H55N11O7S, MW: 906.1(His-Cys-Lys-Phe-Trp-Trp-OH) |
1 mg |
137 |
|
CG52261 |
MF: C46H55N11O7S, MW: 906.1(His-Cys-Lys-Phe-Trp-Trp-OH) |
2 mg |
163 |
|
CG52261 |
MF: C46H55N11O7S, MW: 906.1(His-Cys-Lys-Phe-Trp-Trp-OH) |
5 mg |
228 |
|
CG52262 |
MF: C33H59N11O10, MW: 769.9(Ac-Ala-Arg-Val-Leu-Ala-Glu-Ala-NH2) |
1 mg |
176 |
|
CG52263 |
MF: C68H94N22O27, MW:
1651.6(Thr-Asp-Thr-Ser-His-His-Asp-Gln-Asp-His-Pro-Thr-Phe-Asn-OH) |
1 mg |
189 |
|
CG52264 |
MF: C59H95N15O18S1, MW:
1334.57(H-Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2) |
5 mg |
176 |
|
CG52265 |
MF: C34H50N8O6S, MW: 698.9(Met-Arg-Phe-Phe-Val) |
5 mg |
202 |
|
CG52266 |
MF: C171H298N50O56, MW:
3950.6(Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp-Ile-Ser-His-Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys) |
1 mg |
348 |
|
CG52267 |
MF: C55H76N17O13, MW:
1182.3(pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) |
5 mg |
176 |
|
CG52268 |
MF: C59H75N18O14, MW:
1259.4(pGlu-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2) |
5 mg |
176 |
|
CG52269 |
MF: C70H131N19O15, MW:
1478.9(Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2) |
1 mg |
215 |
|
CG52270 |
MF: C105H160N30O26S4, MW:
2386.8(Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide
bridge Cys7-Cys16)) |
0.5 mg |
189 |
|
CG52270 |
MF: C105H160N30O26S4, MW:
2386.8(Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide
bridge Cys7-Cys16)) |
1 mg |
254 |
|
CG52270 |
MF: C105H160N30O26S4, MW:
2386.8(Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide
bridge Cys7-Cys16)) |
2.5 mg |
371 |
|
CG52271 |
MF: C89H137N27O24S4, MW:
2097.9(Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val(Disulfide
bridge Cys5-Cys14)) |
0.5 mg |
189 |
|
CG52271 |
MF: C89H137N27O24S4, MW:
2097.9(Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val(Disulfide
bridge Cys5-Cys14)) |
1 mg |
254 |
|
CG52271 |
MF: C89H137N27O24S4, MW:
2097.9(Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val(Disulfide
bridge Cys5-Cys14)) |
2.5 mg |
371 |
|
CG52272 |
MF: C131H229N39O31, MW:
2846.5(Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2) |
1 mg |
280 |
|
CG52272 |
MF: C131H229N39O31, MW:
2846.5(Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2) |
2.5 mg |
410 |
|
CG52272 |
MF: C131H229N39O31, MW:
2846.5(Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2) |
0.5 mg |
202 |
|
CG52273 |
MF: C120H188N34O35S, MW:
2699.1(Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln) |
0.5 mg |
202 |
|
CG52273 |
MF: C120H188N34O35S, MW:
2699.1(Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln) |
1 mg |
280 |
|
CG52273 |
MF: C120H188N34O35S, MW:
2699.1(Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln) |
2.5 mg |
410 |
|
CG52274 |
MF: C77H109N21O19S, MW:
1664.9(Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) |
25 mg |
410 |
|
CG52274 |
MF: C77H109N21O19S, MW:
1664.9(Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) |
5 mg |
202 |
|
CG52274 |
MF: C77H109N21O19S, MW:
1664.9(Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2) |
10 mg |
280 |
|
CG52275 |
MF: C118H174N34O35S, MW:
2660.9(Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH) |
5 mg |
410 |
|
CG52275 |
MF: C118H174N34O35S, MW:
2660.9(Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH) |
2 mg |
280 |
|
CG52275 |
MF: C118H174N34O35S, MW:
2660.9(Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp-OH) |
1 mg |
202 |
|
CG52276 |
MF: C72H97N21O14S, MW:
1512.8(Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2) |
5 mg |
371 |
|
CG52276 |
MF: C72H97N21O14S, MW:
1512.8(Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2) |
2 mg |
254 |
|
CG52276 |
MF: C72H97N21O14S, MW:
1512.8(Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2) |
1 mg |
189 |
|
CG52277 |
MF: C126H188N44O37S, MW:
2943.2(Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly-Val-Gly-Gly-Ala-Ala-Gln-OH) |
5 mg |
618 |
|
CG52277 |
MF: C126H188N44O37S, MW:
2943.2(Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly-Val-Gly-Gly-Ala-Ala-Gln-OH) |
1 mg |
267 |
|
CG52277 |
MF: C126H188N44O37S, MW:
2943.2(Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly-Val-Gly-Gly-Ala-Ala-Gln-OH) |
2 mg |
384 |
|
CG52278 |
MF: C74H114N20O17, MW:
1555.86(H-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-OH) |
1 mg |
137 |
|
CG52278 |
MF: C74H114N20O17, MW:
1555.86(H-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-OH) |
2 mg |
163 |
|
CG52278 |
MF: C74H114N20O17, MW:
1555.86(H-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-OH) |
5 mg |
228 |
|
CG52279 |
MF: C71H113N23O28, MW:
1736.8(H-Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn-OH) |
1 mg |
137 |
|
CG52279 |
MF: C71H113N23O28, MW:
1736.8(H-Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn-OH) |
2 mg |
163 |
|
CG52279 |
MF: C71H113N23O28, MW:
1736.8(H-Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn-OH) |
5 mg |
228 |
|
CG52280 |
MF: C52H73N15O12S, MW:
1132.3(Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2) |
1 mg |
137 |
|
CG52280 |
MF: C52H73N15O12S, MW:
1132.3(Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2) |
2 mg |
163 |
|
CG52280 |
MF: C52H73N15O12S, MW:
1132.3(Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2) |
5 mg |
228 |
|
CG52281 |
MF: C50H73N17O11S, MW:
1120.3(Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2) |
1 mg |
176 |
|
CG52282 |
MF: C54H76N14O10, MW: 1081.3(H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2) |
10 mg |
280 |
|
CG52282 |
MF: C54H76N14O10, MW: 1081.3(H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2) |
25 mg |
410 |
|
CG52282 |
MF: C54H76N14O10, MW: 1081.3(H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2) |
5 mg |
202 |
|
CG52283 |
MF: C175H284N52O52S1, MW:
5980.6(H-Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2) |
5 mg |
514 |
|
CG52283 |
MF: C175H284N52O52S1, MW:
5980.6(H-Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2) |
10 mg |
800 |
|
CG52283 |
MF: C175H284N52O52S1, MW:
5980.6(H-Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2) |
25 mg |
Inquire |
|
CG52284 |
MF: C189H285N55O57S1, MW:
4271.78(H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2) |
25 mg |
Inquire |
|
CG52284 |
MF: C189H285N55O57S1, MW:
4271.78(H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2) |
5 mg |
514 |
|
CG52284 |
MF: C189H285N55O57S1, MW:
4271.78(H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2) |
10 mg |
800 |
|
CG52285 |
MF: N/A, MW:
1809.1(Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH) |
2.5 mg |
371 |
|
CG52285 |
MF: N/A, MW:
1809.1(Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH) |
0.5 mg |
189 |
|
CG52285 |
MF: N/A, MW:
1809.1(Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH) |
1 mg |
254 |
|
CG52286 |
MF: C78H121N21O20, MW:
1672.96(pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH) |
5 mg |
176 |
|
CG52287 |
MF: C41H74N12O11, MW: 911.1(Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys) |
1 mg |
176 |
|
CG52288 |
MF: C44H66N12O7S2, MW: 939.2(Ac-Arg-Phe-Met-Trp-Met-Lys-NH2) |
1 mg |
189 |
|
CG52288 |
MF: C44H66N12O7S2, MW: 939.2(Ac-Arg-Phe-Met-Trp-Met-Lys-NH2) |
2 mg |
254 |
|
CG52288 |
MF: C44H66N12O7S2, MW: 939.2(Ac-Arg-Phe-Met-Trp-Met-Lys-NH2) |
5 mg |
371 |
|
CG52290 |
MF: C203H331N63O53S1, MW:
4534.36(H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2) |
2.5 mg |
566 |
|
CG52290 |
MF: C203H331N63O53S1, MW:
4534.36(H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2) |
0.5 mg |
254 |
|
CG52290 |
MF: C203H331N63O53S1, MW:
4534.36(H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2) |
1 mg |
358 |
|
CG52290 |
MF: C203H331N63O65S, MW:
4534.4(His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2) |
0.5 mg |
248 |
|
CG52290 |
MF: C203H331N63O65S, MW:
4534.4(His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2) |
1 mg |
358 |
|
CG52290 |
MF: C203H331N63O65S, MW:
4534.4(His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2) |
2.5 mg |
553 |
|
CG52291 |
MF: C195H298N58O57S, MW:
4398.9(Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2) |
2.5 mg |
488 |
|
CG52291 |
MF: C195H298N58O57S, MW:
4398.9(Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2) |
0.5 mg |
228 |
|
CG52291 |
MF: C195H298N58O57S, MW:
4398.9(Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2) |
1 mg |
358 |
|
CG52292 |
MF: C214H330N68O76S, MW:
5103.4(Gly-Trp-Pro-Gln-Ala-Pro-Ala-Met-Asp-Gly-Ala-Gly-Lys-Thr-Gly-Ala-Glu-Glu-Ala-Gln-Pro-Pro-Glu-Gly-Lys-Gly-Ala-Arg-Glu-His-Ser-Arg-Gln-Glu-Glu-Glu-Glu-Glu-Thr-Ala-Gly-Ala-Pro-Gln-Gly-Leu-Phe-Arg-Gly-NH2) |
2.5 mg |
1.034 |
|
CG52292 |
MF: C214H330N68O76S, MW:
5103.4(Gly-Trp-Pro-Gln-Ala-Pro-Ala-Met-Asp-Gly-Ala-Gly-Lys-Thr-Gly-Ala-Glu-Glu-Ala-Gln-Pro-Pro-Glu-Gly-Lys-Gly-Ala-Arg-Glu-His-Ser-Arg-Gln-Glu-Glu-Glu-Glu-Glu-Thr-Ala-Gly-Ala-Pro-Gln-Gly-Leu-Phe-Arg-Gly-NH2) |
0.5 mg |
410 |
|
CG52292 |
MF: C214H330N68O76S, MW:
5103.4(Gly-Trp-Pro-Gln-Ala-Pro-Ala-Met-Asp-Gly-Ala-Gly-Lys-Thr-Gly-Ala-Glu-Glu-Ala-Gln-Pro-Pro-Glu-Gly-Lys-Gly-Ala-Arg-Glu-His-Ser-Arg-Gln-Glu-Glu-Glu-Glu-Glu-Thr-Ala-Gly-Ala-Pro-Gln-Gly-Leu-Phe-Arg-Gly-NH2) |
1 mg |
618 |
|
CG52293 |
MF: C185H287N53O54S2, MW:
4181.8(H-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2) |
2.5 mg |
371 |
|
CG52293 |
MF: C185H287N53O54S2, MW:
4181.8(H-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2) |
1 mg |
254 |
|
CG52293 |
MF: C185H287N53O54S2, MW:
4181.8(H-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2) |
0.5 mg |
189 |
|
CG52294 |
MF: C183H288N54O50S2, MW:
4108.7(Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe) |
0.5 mg |
228 |
|
CG52294 |
MF: C183H288N54O50S2, MW:
4108.7(Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe) |
1 mg |
358 |
|
CG52294 |
MF: C183H288N54O50S2, MW:
4108.7(Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe) |
2.5 mg |
488 |
|
CG52295 |
MF: C35H55N9O16, MW: 857.8(Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-OH) |
1 mg |
144 |
|
CG52296 |
MF: C194H295N55O57, MW:
4309.8(Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2) |
1 mg |
293 |
|
CG52296 |
MF: C194H295N55O57, MW:
4309.8(Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2) |
2 mg |
436 |
|
CG52296 |
MF: C194H295N55O57, MW:
4309.8(Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2) |
5 mg |
696 |
|
CG52297 |
MF: C190H288N54O57, MW:
4240.7(Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2) |
5 mg |
696 |
|
CG52297 |
MF: C190H288N54O57, MW:
4240.7(Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2) |
1 mg |
293 |
|
CG52297 |
MF: C190H288N54O57, MW:
4240.7(Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2) |
2 mg |
436 |
|
CG52298 |
MF: C72H104N20O17, MW:
1521.7(His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe-OH) |
1 mg |
176 |
|
CG52298 |
MF: C72H104N20O17, MW:
1521.7(His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe-OH) |
5 mg |
397 |
|
CG52299 |
MF: C88H162N26O22S, MW:
1968.5(Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-Gly-Lys-Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2) |
1 mg |
267 |
|
CG52300 |
MF: C136H216N36O40, MW:
2995.4(His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Arg-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH2) |
1 mg |
228 |
|
CG52300 |
MF: C136H216N36O40, MW:
2995.4(His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Arg-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH2) |
2 mg |
358 |
|
CG52300 |
MF: C136H216N36O40, MW:
2995.4(His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Arg-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH2) |
5 mg |
488 |
|
CG52301 |
MF: C160H252N56O42S, MW:
3664.2(Ser-Arg-Thr-His-Arg-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2) |
1 mg |
332 |
|
CG52302 |
MF: C61H85N16O13S, MW:
1281.5(pGlu-Val-Pro-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2) |
5 mg |
176 |
|
CG52303 |
MF: C90H134N30O24S, MW:
2052.3(Ser-Asn-Thr-Ala-Leu-Arg-Arg-Tyr-Asn-Gln-Trp-Ala-Thr-Gly-His-Phe-Met-NH2) |
2 mg |
293 |
|
CG52303 |
MF: C90H134N30O24S, MW:
2052.3(Ser-Asn-Thr-Ala-Leu-Arg-Arg-Tyr-Asn-Gln-Trp-Ala-Thr-Gly-His-Phe-Met-NH2) |
5 mg |
462 |
|
CG52303 |
MF: C90H134N30O24S, MW:
2052.3(Ser-Asn-Thr-Ala-Leu-Arg-Arg-Tyr-Asn-Gln-Trp-Ala-Thr-Gly-His-Phe-Met-NH2) |
1 mg |
215 |
|
CG52304 |
MF: C22H33N7O8, MW: 523.5(Arg-Phe-Asp-Ser-OH) |
25 mg |
137 |
|
CG52305 |
MF: C12H22N6O6, MW: 346.3(Arg-Gly-Asp-OH) |
25 mg |
176 |
|
CG52306 |
MF: C15H27N7O8, MW: 433.4(Arg-Gly-Asp-Ser-OH) |
5 mg |
137 |
|
CG52307 |
MF: C17H31N7O7, MW: 445.5(Arg-Gly-Asp-Val-OH) |
25 mg |
176 |
|
CG52308 |
MF: C202H348N56O64S, MW:
4617.43(pGlu-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2) |
0.5 mg |
254 |
|
CG52308 |
MF: C202H348N56O64S, MW:
4617.43(pGlu-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2) |
1 mg |
358 |
|
CG52308 |
MF: C202H348N56O64S, MW:
4617.43(pGlu-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2) |
2.5 mg |
566 |
|
CG52309 |
MF: C130H220N44O40, MW:
3039.47(H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2) |
1 mg |
202 |
|
CG52309 |
MF: C130H220N44O40, MW:
3039.47(H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2) |
2 mg |
280 |
|
CG52309 |
MF: C130H220N44O40, MW:
3039.47(H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2) |
5 mg |
410 |
|
CG52310 |
MF: C130H220N44O41, MW:
3055.41(His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2) |
|
Inquire |
|
CG52310 |
MF: C130H220N44O41, MW:
3055.47(H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2) |
25 mg |
982 |
|
CG52312 |
MF: C42H66N10O16S2, MW: 1031.2(Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val-OH) |
1 mg |
176 |
|
CG52313 |
MF: C145H234N52O44S3, MW:
3506(Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
(Disulfide bridge Cys11- Cys 27)) |
1 mg |
332 |
|
CG52314 |
MF: C204H337N63O64, MW:
4696.3(H-Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2) |
1 mg |
358 |
|
CG52314 |
MF: C204H337N63O64, MW:
4696.3(H-Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2) |
2.5 mg |
488 |
|
CG52314 |
MF: C204H337N63O64, MW:
4696.3(H-Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2) |
0.5 mg |
228 |
|
CG52315 |
MF: C207H308N56O58S, MW:
4541.1(Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe) |
1 mg |
280 |
|
CG52316 |
MF: C 30H49N9O9, MW: 679.8(H-Arg-Lys-Asp-Val-Tyr-OH) |
25 mg |
371 |
|
CG52316 |
MF: C 30H49N9O9, MW: 679.8(H-Arg-Lys-Asp-Val-Tyr-OH) |
5 mg |
189 |
|
CG52316 |
MF: C 30H49N9O9, MW: 679.8(H-Arg-Lys-Asp-Val-Tyr-OH) |
10 mg |
254 |
|
CG52437 |
MF: C29H44N10O7, MW: 644.7(Boc-Gly-Arg-Arg-AMC) |
20 mg |
355 |
|
CG52438 |
MF: C33H53N13O7, MW: 743.8(Boc-Arg-Arg-Arg-AMC) |
20 mg |
355 |
|
CG52439 |
MF: C32H48N10O7, MW: 684.8(Boc-Pro-Arg-Arg-AMC) |
20 mg |
355 |
|
CG52440 |
MF: C44H63N11O6, MW: 906(Boc-Phe-Ala-Ala-Gly-Arg-Lys-AMC) |
20 mg |
514 |
|
CG52487 |
MF: C203H311N55O60S1 , MW:
514.14(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH) |
1 mg |
384 |
|
CG52487 |
MF: C203H311N55O60S1 , MW:
514.14(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH) |
2.5 mg |
618 |
|
CG52487 |
MF: C203H311N55O60S1 , MW:
514.14(H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH) |
0.5 mg |
267 |
|
CG52524 |
MF: C15H26N7O7S1, MW: 448.48(H-Arg-Gly-Asp-Cys-OH) |
25 mg |
176 |
|
CG52539 |
MF: C45H73N19O24, MW:
1264.2(H-Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp-OH) |
1 mg |
189 |
|
CG52539 |
MF: C45H73N19O24, MW:
1264.2(H-Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp-OH) |
2 mg |
254 |
|
CG52539 |
MF: C45H73N19O24, MW:
1264.2(H-Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp-OH) |
5 mg |
371 |
|
CG52553 |
MF: C18H25N5O5S, MW: 423.4(Met-Gly-Pro-pNA) |
1 mg |
137 |
|
CG52553 |
MF: C18H25N5O5S, MW: 423.4(Met-Gly-Pro-pNA) |
10 mg |
228 |
|
CG52621 |
MF: C32H61N13O9, MW: 771.92(H-Leu-Arg-Arg-Ala-Ser-Leu-Gly-OH) |
5 mg |
176 |
|
CG52752 |
MF: C149H229N40O45, MW:
3297.7(H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2) |
0.5 mg |
202 |
|
CG52752 |
MF: C149H229N40O45, MW:
3297.7(H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2) |
1 mg |
280 |
|
CG52752 |
MF: C149H229N40O45, MW:
3297.7(H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2) |
2.5 mg |
410 |
|
CG52834 |
MF: C32H41N9O9, MW: 695.7(Suc-Arg-Gly-Pro-Phe-pNA) |
1 mg |
150 |
|
CG52834 |
MF: C32H41N9O9, MW: 695.7(Suc-Arg-Gly-Pro-Phe-pNA) |
10 mg |
306 |
|
CG52835 |
MF: C35H44N6O11, MW: 724.7(Suc-Leu-Glu-Pro-Phe-pNA) |
1 mg |
150 |
|
CG52835 |
MF: C35H44N6O11, MW: 724.7(Suc-Leu-Glu-Pro-Phe-pNA) |
10 mg |
306 |
|
CG52836 |
MF: C31H36N6O12, MW: 684.6(Sue-Ser-Asp-Pro-Phe-pNA) |
1 mg |
150 |
|
CG52836 |
MF: C31H36N6O12, MW: 684.6(Sue-Ser-Asp-Pro-Phe-pNA) |
10 mg |
306 |
|
CG52986 |
MF: C26H34N8O7S, MW: 602(N(p-Tosyl)-Gly-Pro-Arg-pNA) |
100 mg |
540 |
|
CG53577 |
MF: C41H60N10O20, MW: 1012.99(H-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH) |
2.5 mg |
163 |
|
CG53597 |
MF: C51H86N12O21, MW:
1203.32(H-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-OH) |
5 mg |
176 |
|
CG53599 |
MF: C53H67N9O17, MW: 1102.18(H-Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala-OH) |
1 mg |
137 |
|
CG53599 |
MF: C53H67N9O17, MW: 1102.18(H-Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala-OH) |
2 mg |
163 |
|
CG53599 |
MF: C53H67N9O17, MW: 1102.18(H-Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala-OH) |
5 mg |
228 |
|
CG53660 |
MF: C26H35N8O7S, MW: 809.9(Fmoc-Lys(Boc)-Leu-Lys(Boc)) |
1000 mg |
813 |
|
CG53663 |
MF: C35H59N5O8, MW: 667.9(Lys(Boc)-Leu-Lys(Boc)-OBzl) |
1000 mg |
748 |
|
CG53698 |
MF: C45H74N10O13, MW: 963.2(Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH) |
1 mg |
176 |
|
CG53698 |
MF: C45H74N10O13, MW: 963.2(Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH) |
2 mg |
202 |
|
CG53698 |
MF: C45H74N10O13, MW: 963.2(Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu-OH) |
5 mg |
293 |
|
CG53770 |
MF: C190H291N51O57S1, MW:
4233.81(H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-) |
0.5 mg |
267 |
+32 1658 9045
+32 1650 9045
